Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed revenue channel.
In-vitro studies confirmed strong uptake of cell-targeting nanoparticles by cancer cells and strong activation of Smart mRNAs inside cancer cells
Peel Therapeutics CEO Joshua Schiffman Presents at CureCRC Summit
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas
Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History
Talent Ready Utah Calling for Innovator Input
TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription marks first international expansion of the Company’s recurring-revenue platform.
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12).
New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement.
FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8.
Prestigious recognition validates Canary Speech’s leadership in healthcare-focused AI voice technology and its proven interoperability with the Microsoft Cloud
bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia
PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible
Milestone enables immediate production of SiN/PEEK custom devices
By Henry O’Connell, CEO and co-founder of Canary Speech Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the human voice to assist in diagnoses is established fact. Providers already possess technological platforms that make informed care […]
SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The […]
This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet’s data through Locus Health’s platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in […]
SALT LAKE CITY, November 19, 2025— With a deadline approaching on January 31, 2026, ARUP Laboratories has joined other clinical laboratories in advocating for passage of the federal Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, which would block looming cuts in payments for lab testing services, relieve labs of burdensome reporting, […]
The 2025 BioUtah Utah Life Sciences Summit (ULSS) took place November 12 at the Hilton Salt Lake City Center, featuring keynote speakers, awards, educational sessions, networking opportunities, and the signing of a Memorandum of Understanding (MOU) with the Korea Health Industry Development Institute. With 650 registrants, this year’s Summit was the biggest yet. Jefferson Moss, […]
100% of genes strongly recommended by national oncology guidelines are included in the MyRisk Test.
Salt Lake City, UT –Wednesday November, 5th 2025— Researchers from the University of Utah and Microvascular Therapeutics (MVT) will be presenting new preclinical data demonstrating that focused ultrasound (FUS) using proprietary phase-shift microbubbles, NanoBlate (MVT-101), can selectively ablate brain tumors and open the blood-brain barrier (BBB) in targeted regions, potentially enabling safer, more precise, and […]
Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared.
Investigator-Initiated, grant-supported pilot study evaluating a novel non-prescription therapy for cancer-related vaginal dryness.
BioUtah will honor outstanding leaders in Utah’s life sciences community with five awards recognizing contributions to the industry.
PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial
The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 months
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives
Health insurance costs are projected to rise sharply in 2026
Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics
Earning the first-ever SGS Cybersecurity Mark in the baby monitor category, Owlet reinforces its leadership in safety, security, privacy, and innovation.
